Telehealth or a local clinic for GLP-1 care?
Last reviewed September 17, 2026 · reviewed quarterly
What this page does not do. This page compares general features of telehealth and in-person GLP-1 care. It is not medical advice, does not recommend any company or clinic, and does not tell you whether a medication or dose is right for you.
Both can be legitimate
Good GLP-1 care can happen by video or in an exam room. The same basic protections apply either way.
- Licensing: clinicians must be licensed or legally permitted to practice in the state where the patient is located, wherever the clinician is.
- Prescription and pharmacy: FDA advises patients to get a prescription from a doctor and fill it at a state-licensed pharmacy.
- Warning signs: FDA's red flags for online services include not requiring a screening and prescription, and having no licensed doctor available to answer questions after the medicine arrives.
The differences are mostly practical: how labs and exams happen, how follow-up works, who you see over time, and how you pay.
Labs and in-person exams
FDA labeling asks prescribers to know a patient's history and to watch for certain problems. The Wegovy and Zepbound labels, for example:
- tell prescribers not to use the drug in people with a personal or family history of medullary thyroid carcinoma or MEN 2
- call for monitoring kidney function in patients whose side effects could lead to dehydration
- call for watching diabetic eye disease in patients with a history of it
- for Wegovy, call for monitoring heart rate at regular intervals, and blood glucose in patients with diabetes
Local clinic: a clinician can take your weight, blood pressure and heart rate in person, examine you, and often draw blood on site. Results land in the same record the clinician uses.
Telehealth: the service may send you to a commercial lab, accept recent results from your own doctor, or rely on measurements you take at home. Ask which labs, if any, are required before a prescription, who reviews the results, and whether you pay for them separately.
Follow-up and dose changes
The labels describe starting at a low dose and increasing in steps over time. They also warn about gastrointestinal side effects, which can sometimes be severe. In practice, that means ongoing check-ins rather than a one-time prescription.
Local clinic: follow-up may be a scheduled office visit, sometimes with nurse calls or portal messages in between.
Telehealth: follow-up may be an online questionnaire, a message thread or a short video visit.
Either way, ask:
- How often will someone review how I'm doing before a dose change?
- How do I report side effects, and how fast will I hear back?
- What should I do after hours?
Continuity of care
Local clinic: you are more likely to see the same clinician over time. The clinic can coordinate with your primary care doctor and any specialists.
Telehealth: you may see whichever clinician is available. Ask whether you can stay with one clinician, and whether visit notes can be shared with your regular doctor.
Whichever you choose, keep your own copies. You have a legal right under HIPAA to see and get copies of your health information, usually within 30 days, and many practices offer a portal where you can download it. Saving your visit notes, lab results and prescription details periodically makes any later switch much easier.
Also find out which pharmacy fills your prescription. FDA notes that people who buy compounded drugs through online platforms may not know who actually made them.
If a telehealth service stops serving your state
A telehealth clinician can treat you only where they are licensed or otherwise legally permitted to practice, based on where you are located. A service may stop offering care in a state, or you may move. Either way, your prescriptions and follow-up may need a new clinician licensed in your state. A local clinic is less exposed to this, although clinics also close or stop taking new patients.
To reduce disruption, keep a current list of:
- your medication, strength and pharmacy
- the date of your last dose change
- recent lab results
See what to do if your telehealth provider shuts down.
How programs charge
| Model | What you typically pay for | Questions to ask |
|---|---|---|
| Per visit | Each visit or message-based consult; medication separate | Are follow-up messages billed? |
| Membership | A monthly or annual fee for access to a clinician; medication usually separate | What happens to my care if I cancel? |
| Bundled program | One fee that may include visits and medication | Exactly which drug, and from which pharmacy? Does the price change with the dose? |
| Insurance-billed visits | Your usual copay or deductible for visits | Is the drug itself covered, and is prior authorization needed? |
As one snapshot, as of September 2026 Lilly's LillyDirect page listed independent telehealth options for obesity care with prices such as:
- insurance-billed visits averaging $25 to $31
- self-pay visits from $29 to $299
- memberships of $99 to $149 a month, with lower annual pricing
Lilly says it does not endorse these providers and that the rates do not include medication. A local clinic usually bills visits to your insurance. Some clinics also offer cash-pay packages, so ask what is included.
Finding care near you
Neither option is right for everyone. What matters is a licensed clinician who follows up, a licensed pharmacy, and records you can take with you. If you'd like to see in-person options, you can find a clinic near you or browse clinics by state and compare them with telehealth services licensed where you live.
Find care
Clinics that confirm GLP-1 or weight-management care on their own websites, and online options verified for your state.
Sources
- Getting started with licensure · Telehealth.HHS.gov (U.S. Department of Health and Human Services) · accessed September 17, 2026
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration · accessed September 17, 2026
- Compounding and the FDA: Questions and Answers · U.S. Food and Drug Administration · accessed September 17, 2026
- WEGOVY (semaglutide) injection and tablets: Prescribing Information (revised 06/2026) · U.S. Food and Drug Administration (Drugs@FDA) · accessed September 17, 2026
- ZEPBOUND (tirzepatide) injection: Prescribing Information (revised 02/2026) · U.S. Food and Drug Administration (Drugs@FDA) · accessed September 17, 2026
- Get it. Check it. Use it. · U.S. Department of Health and Human Services, Office for Civil Rights · accessed September 17, 2026
- LillyDirect: Find telehealth care · Eli Lilly and Company · accessed September 17, 2026
GLP-1 Care Map lists providers and patient-reported information. It is not medical advice and does not recommend any provider or treatment. We do not verify licensure, and services and prices change: confirm details with the provider before you book.